GO:0033274 response to vitamin B2: Cellular Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033274 (response to vitamin B2) describes any cellular or organismal process that changes state or activity in response to a vitamin B2 (riboflavin) stimulus.
• Riboflavin is the precursor of the coenzymes FMN and FAD, which are essential for mitochondrial fatty acid oxidation, redox reactions, and energy metabolism.
• Disorders of riboflavin metabolism, including those caused by variants in FLAD1 and ETFDH, can present as riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.
• A conserved vitamin-B2-sensing mechanism regulates gut protease activity and impacts food behavior and growth in animals.
• Dietary vitamin B2 intake has been studied in relation to breast cancer risk, with meta-analyses suggesting a possible protective association.
• Vitamin B2 nutrigenomics has revealed a potential therapy for NAXD disease, a rare neurodegenerative disorder.
Description
GO:0033274, response to vitamin B2, is a biological process term in the Gene Ontology that captures how cells and organisms detect and react to vitamin B2 (riboflavin). Riboflavin is a water-soluble vitamin that serves as the precursor for the essential coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which participate in a wide range of oxidation-reduction reactions and energy metabolism. The response to vitamin B2 encompasses changes in gene expression, enzyme production, metabolic flux, and physiological behavior that occur when cells encounter this vitamin. Understanding this process is critical because riboflavin deficiency and genetic defects in riboflavin transport or utilization lead to severe clinical phenotypes, including multiple acyl-CoA dehydrogenation deficiency and neurodegenerative disease. Moreover, vitamin B2 status influences immune responses and cancer risk, making it a topic of active research in nutrigenomics and precision medicine. This article provides a research-grade overview of GO:0033274, integrating authoritative Gene Ontology definitions with verified PubMed literature to support experimental design and therapeutic hypothesis generation.
response to vitamin B2 At A Glance
| GO ID | GO:0033274 |
|---|---|
| GO term | response to vitamin B2 |
| Ontology | biological_process |
| Synonym | response to riboflavin |
| Major function | Cellular and organismal adaptation to vitamin B2 (riboflavin) availability, including regulation of flavoenzyme synthesis and metabolic flux |
| Related coenzymes | FMN and FAD, derived from riboflavin |
| Associated diseases | Multiple acyl-CoA dehydrogenation deficiency, NAXD disease, riboflavin deficiency |
| Key genes | FLAD1, ETFDH, SLC52A1, SLC52A2, SLC52A3, ACADM, ACADVL, ETFA, ETFB, NAXD, NAXE |
| Research methods | CRISPR knockout, RNA-seq, proteomics, metabolomics, riboflavin supplementation assays |
What Is GO:0033274?
According to the Gene Ontology, GO:0033274 (response to vitamin B2) is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B2 stimulus. The synonym response to riboflavin is also used. This term is a biological process and encompasses the sensing, signaling, and downstream effector mechanisms that are triggered when vitamin B2 levels change, including transcriptional, translational, and metabolic adaptations.
Why Is response to vitamin B2 Important in Cell Biology?
GO:0033274 is important because riboflavin is an essential micronutrient that cannot be synthesized by humans, and its derivatives FMN and FAD are required for the function of numerous flavoenzymes involved in mitochondrial fatty acid oxidation, amino acid catabolism, and oxidative phosphorylation. Defects in riboflavin transport or metabolism cause riboflavin-responsive disorders, and understanding the response to vitamin B2 can guide therapeutic supplementation strategies. Furthermore, vitamin B2 status has been linked to immune checkpoint blockade responses and cancer risk, highlighting its broader clinical relevance.
• Riboflavin is the precursor of FMN and FAD, essential cofactors for mitochondrial fatty acid oxidation and redox metabolism.
• Mutations in FLAD1 and ETFDH cause riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency, a treatable inborn error of metabolism.
• A conserved vitamin-B2-sensing mechanism regulates gut protease activity and impacts animal food behavior and growth.
• Vitamin B2 nutrigenomics has identified a potential therapy for NAXD disease, a rare neurodegenerative disorder.
• Dietary vitamin B2 intake has been associated with breast cancer risk in meta-analyses, suggesting a role in cancer prevention.
• Riboflavin status may influence response to immune checkpoint blockade therapy through microbial metabolic pathways.
• Recurrent aphthous ulceration has been linked to vitamin B2 status and response to replacement therapy.
• Understanding GO:0033274 aids in designing CRISPR models to study flavoenzyme-related diseases and metabolic disorders.
What Happens During response to vitamin B2?
Sensing of vitamin B2 availability
In simple terms: Cells first detect how much vitamin B2 is available.
The response to vitamin B2 begins with sensing changes in intracellular or extracellular riboflavin levels. In animals, a conserved vitamin-B2-sensing mechanism regulates gut protease activity, impacting food behavior and growth. This sensing likely involves transport proteins such as SLC52A1, SLC52A2, and SLC52A3, which mediate riboflavin uptake. The exact molecular sensors are still being elucidated, but the process is known to trigger downstream signaling that adjusts cellular metabolism.
Transcriptional and translational regulation of flavoenzymes
In simple terms: The cell changes which genes and proteins it makes to handle the vitamin.
Upon vitamin B2 stimulus, cells alter gene expression to produce enzymes that utilize FMN and FAD. For example, riboflavin supplementation can upregulate or stabilize flavoenzymes such as ETFDH and FLAD1, which are involved in mitochondrial fatty acid oxidation. In riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency, variants in FLAD1 and ETFDH lead to impaired flavoenzyme function that can be rescued by riboflavin. This regulation ensures adequate coenzyme availability for metabolic pathways.
Metabolic adaptation and coenzyme homeostasis
In simple terms: The cell adjusts its metabolism to use the vitamin efficiently.
Riboflavin is converted to FMN by riboflavin kinase and then to FAD by FAD synthetase. The response to vitamin B2 includes maintaining homeostasis of these coenzymes. In NAXD disease, mutations in NAXD lead to accumulation of damaged metabolites, and vitamin B2 nutrigenomics has revealed a potential therapy by modulating this pathway. Metabolic adaptation involves shifts in fatty acid oxidation, amino acid catabolism, and oxidative phosphorylation to match coenzyme availability.
Physiological and behavioral outcomes
In simple terms: The whole organism may change its behavior or growth in response to the vitamin.
At the organismal level, response to vitamin B2 can affect food behavior and growth, as shown by a vitamin-B2-sensing mechanism that regulates gut protease activity. In humans, riboflavin status has been linked to recurrent aphthous ulceration, with replacement therapy improving symptoms. These outcomes reflect the integration of cellular responses into systemic physiology.
Interaction with immune and cancer pathways
In simple terms: Vitamin B2 responses can influence how the immune system fights cancer.
Microbial metabolic pathways, including those involving vitamin B2, guide response to immune checkpoint blockade therapy. Additionally, dietary vitamin B2 intake has been studied in relation to breast cancer risk, with meta-analyses suggesting an inverse association. These findings indicate that response to vitamin B2 intersects with immunology and oncology, potentially through effects on flavoenzyme-dependent redox signaling.
Key Genes Involved in GO:0033274 response to vitamin B2
The following genes are central to the response to vitamin B2, based on verified literature linking them to riboflavin metabolism, transport, and flavoenzyme function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FLAD1 | FAD synthetase; converts FMN to FAD | Variants cause riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency |
| ETFDH | Electron-transferring-flavoprotein dehydrogenase; mitochondrial fatty acid oxidation | Mutations lead to riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency |
| SLC52A1 | Riboflavin transporter | Mediates cellular uptake of vitamin B2 |
| SLC52A2 | Riboflavin transporter | Defects cause Brown-Vialetto-Van Laere syndrome |
| SLC52A3 | Riboflavin transporter | Defects cause Brown-Vialetto-Van Laere syndrome |
| ACADM | Medium-chain acyl-CoA dehydrogenase; fatty acid oxidation | Flavoenzyme dependent on FAD; relevant to riboflavin deficiency |
| ACADVL | Very long-chain acyl-CoA dehydrogenase; fatty acid oxidation | Flavoenzyme dependent on FAD; relevant to riboflavin deficiency |
| ETFA | Electron transfer flavoprotein alpha subunit | Flavoenzyme involved in mitochondrial fatty acid oxidation |
| ETFB | Electron transfer flavoprotein beta subunit | Flavoenzyme involved in mitochondrial fatty acid oxidation |
| NAXD | NAD(P)HX epimerase; repairs damaged NADH | Mutations cause NAXD disease; vitamin B2 nutrigenomics reveals therapy |
| NAXE | NAD(P)HX epimerase; repairs damaged NADH | Related to NAXD pathway; potential riboflavin responsiveness |
| RFK | Riboflavin kinase; converts riboflavin to FMN | Key enzyme in coenzyme biosynthesis |
| FLAD1 | FAD synthetase; converts FMN to FAD | Key enzyme in coenzyme biosynthesis |
| SLC52A1 | Riboflavin transporter | Potential target for modulating vitamin B2 response |
| SLC52A2 | Riboflavin transporter | Potential target for modulating vitamin B2 response |
| SLC52A3 | Riboflavin transporter | Potential target for modulating vitamin B2 response |
| ETFDH | Electron-transferring-flavoprotein dehydrogenase | Biomarker for riboflavin responsiveness |
How Is response to vitamin B2 Regulated?
The response to vitamin B2 is regulated at multiple levels. Transcriptional regulation of flavoenzyme genes such as ETFDH and FLAD1 can be influenced by riboflavin availability, as evidenced by riboflavin-responsive phenotypes in patients with variants in these genes. Post-translational regulation includes the stability and activity of flavoenzymes, which depend on FAD binding. Additionally, a conserved vitamin-B2-sensing mechanism regulates gut protease activity, impacting food behavior and growth, suggesting hormonal or neural regulation. Microbial metabolic pathways involving vitamin B2 can modulate immune checkpoint blockade responses, indicating regulation by the gut microbiome. However, the precise molecular regulators, such as mTOR or ISR, are not explicitly defined in the verified literature for this term.
response to vitamin B2 and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FLAD1 | Riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency | CRISPR knockout in HEK293 or patient fibroblasts |
| ETFDH | Riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency | Knockout in myoblasts or hepatocytes |
| NAXD | NAXD disease (neurodegeneration) | Knockout in neurons or iPSC-derived models |
| SLC52A2 | Brown-Vialetto-Van Laere syndrome | Knockout in motor neurons |
| SLC52A3 | Brown-Vialetto-Van Laere syndrome | Knockout in motor neurons |
Riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency
Variants in FLAD1 and ETFDH cause multiple acyl-CoA dehydrogenation deficiency, a disorder of mitochondrial fatty acid oxidation that can be riboflavin-responsive. A comparative study showed that patients with FLAD1 variants may have a different response compared to those with ETFDH variants, highlighting the importance of genetic diagnosis for treatment. Riboflavin supplementation can rescue flavoenzyme function in some cases, making early detection critical.
NAXD disease and neurodegenerative disorders
NAXD disease is a rare neurodegenerative disorder caused by mutations in NAXD, leading to accumulation of damaged NADH metabolites. Vitamin B2 and B3 nutrigenomics has revealed a potential therapy for NAXD disease, demonstrating that modulating riboflavin metabolism can ameliorate disease phenotypes. This underscores the therapeutic potential of targeting response to vitamin B2 in neurodegeneration.
Cancer risk and immune checkpoint blockade
Dietary vitamin B2 intake has been associated with breast cancer risk in a systematic review and meta-analysis, suggesting a protective effect. Additionally, microbial metabolic pathways involving vitamin B2 guide response to immune checkpoint blockade therapy, indicating that vitamin B2 status may influence cancer immunotherapy outcomes. These findings link response to vitamin B2 to oncology and immunology.
Recurrent aphthous ulceration
Recurrent aphthous ulceration has been linked to vitamin B1, B2, and B6 status, with replacement therapy improving symptoms in some patients. This suggests that response to vitamin B2 plays a role in oral mucosal health and that deficiency may contribute to ulcer formation.
From response to vitamin B2-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FLAD1 loss cause riboflavin-responsive metabolic defects? | CRISPR knockout of FLAD1 in HEK293 cells |
| Can a point mutation in ETFDH mimic patient phenotype? | Point mutation knock-in of ETFDH variants in myoblasts |
| Does overexpression of SLC52A2 increase riboflavin uptake? | Overexpression of SLC52A2 in HeLa cells |
| What is the role of NAXD in neurodegeneration? | Knockout of NAXD in iPSC-derived neurons |
| How does vitamin B2 sensing affect gut protease activity? | Knockout of candidate sensor in zebrafish or mouse models |
| Does riboflavin supplementation rescue immune checkpoint blockade response? | Knockout of riboflavin transporters in mouse tumor models |
How to Study the response to vitamin B2 Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify transcriptional response to vitamin B2 |
| Proteomics | Protein abundance and modifications | Quantify flavoenzyme levels |
| Metabolomics | Metabolite concentrations | Measure fatty acid oxidation intermediates |
| CRISPR knockout screening | Gene essentiality and resistance | Discover regulators of riboflavin response |
| Fluorescent reporters | Intracellular FAD/FMN levels | Monitor coenzyme homeostasis |
| Western blot | Specific protein expression | Validate ETFDH or FLAD1 levels |
| Enzyme activity assays | Flavoenzyme catalytic activity | Assess riboflavin responsiveness |
Transcriptomics and RNA-seq
RNA sequencing can measure global changes in gene expression in response to vitamin B2 stimulus. For example, comparing riboflavin-supplemented versus deficient cells can reveal upregulation of flavoenzyme genes such as ETFDH and FLAD1. This method is useful for identifying transcriptional networks regulated by GO:0033274.
Proteomics and metabolomics
Proteomic profiling can quantify flavoenzyme abundance, while metabolomics can measure intermediates of fatty acid oxidation and redox metabolism. In NAXD disease, metabolomics revealed accumulation of damaged NADH metabolites that were reversed by vitamin B2 nutrigenomics. These methods provide functional readouts of the response to vitamin B2.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for response to vitamin B2. For instance, screening for resistance to riboflavin depletion can uncover transporters and metabolic enzymes. This approach is powerful for discovering novel regulators of GO:0033274.
Imaging and reporter assays
Fluorescent reporters of FAD or FMN can visualize coenzyme levels in live cells. Additionally, imaging of mitochondrial morphology can assess the impact of riboflavin on fatty acid oxidation. These techniques allow real-time monitoring of the response to vitamin B2.
How CRISPR Can Be Used to Study GO:0033274 response to vitamin B2
Knockout
CRISPR knockout of genes such as FLAD1 or ETFDH can model riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. These models help determine whether loss of function causes metabolic defects that can be rescued by vitamin B2 supplementation. Knockout of SLC52A2 or SLC52A3 can mimic riboflavin transporter deficiency.
Point Mutation
Point mutation knock-in of patient-specific variants, such as those in ETFDH or FLAD1, allows precise modeling of riboflavin-responsive disorders. This approach can reveal genotype-phenotype correlations and differential responses to riboflavin.
Knock-in
Knock-in of tagged versions of flavoenzymes, such as ETFDH-GFP, enables tracking of protein localization and stability in response to vitamin B2. This can elucidate trafficking and turnover mechanisms.
Overexpression
Overexpression of riboflavin transporters like SLC52A2 or metabolic enzymes like FLAD1 can enhance cellular response to vitamin B2. This is useful for studying gain-of-function effects and for engineering cells with increased riboflavin utilization.
How EDITGENE Supports response to vitamin B2 Research
Researchers studying response to vitamin B2-related genes often need to determine whether a candidate gene is causally involved in riboflavin sensing, transport, or metabolic adaptation. EDITGENE provides comprehensive CRISPR gene editing services to create knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies of GO:0033274.
Contact EDITGENE today to design your custom CRISPR model for response to vitamin B2 research.
Frequently Asked Questions About response to vitamin B2
What is GO:0033274 response to vitamin B2?
GO:0033274 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a vitamin B2 stimulus.
What genes are involved in response to vitamin B2?
Key genes include FLAD1, ETFDH, SLC52A1, SLC52A2, SLC52A3, ACADM, ACADVL, ETFA, ETFB, NAXD, and NAXE.
What diseases are linked to vitamin B2 response?
Diseases include riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency, NAXD disease, Brown-Vialetto-Van Laere syndrome, and recurrent aphthous ulceration.
How is response to vitamin B2 studied?
It is studied using RNA-seq, proteomics, metabolomics, CRISPR screening, and fluorescent reporters.
What is the role of riboflavin in metabolism?
Riboflavin is the precursor of FMN and FAD, essential coenzymes for fatty acid oxidation, redox reactions, and energy metabolism.
Can vitamin B2 supplementation treat genetic disorders?
Yes, riboflavin supplementation can rescue some cases of multiple acyl-CoA dehydrogenation deficiency caused by FLAD1 or ETFDH variants.
What is the connection between vitamin B2 and cancer?
Dietary vitamin B2 intake has been associated with breast cancer risk, and microbial vitamin B2 pathways influence immune checkpoint blockade therapy.
What is NAXD disease?
NAXD disease is a neurodegenerative disorder caused by mutations in NAXD, and vitamin B2 nutrigenomics has revealed a potential therapy.
How does vitamin B2 affect gut function?
A conserved vitamin-B2-sensing mechanism regulates gut protease activity, impacting food behavior and growth.
What CRISPR models are available for studying response to vitamin B2?
EDITGENE offers knockout, point mutation, knock-in, overexpression models, and CRISPR library screening for genes like FLAD1, ETFDH, and SLC52A2.
Conclusion
GO:0033274 response to vitamin B2 is a critical biological process that encompasses sensing, transcriptional regulation, metabolic adaptation, and physiological outcomes triggered by riboflavin. Its importance spans inherited metabolic disorders, neurodegeneration, cancer, and immunology, as evidenced by riboflavin-responsive deficiencies and nutrigenomic therapies. Leveraging CRISPR models and multi-omics approaches will continue to unravel the mechanisms of this process and translate them into clinical interventions.
References
- 1. Garg A et al.. 2026. Vitamin B2 and B3 nutrigenomics reveals a therapy for NAXD disease.. Cell 189(9):2648-2662.e19 PMID: 41747729
- 2. Mimpen IL et al.. 2026. Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.. Cancer Discov 16(1):95-113 PMID: 40996449
- 3. Wen B et al.. 2024. A comparative study on riboflavin responsive multiple acyl-CoA dehydrogenation deficiency due to variants in FLAD1 and ETFDH gene.. J Hum Genet 69(3-4):125-131 PMID: 38228875
- 4. Pinto JT et al.. 2016. Riboflavin.. Adv Nutr 7(5):973-5 PMID: 27633112
- 5. Balasubramaniam S et al.. 2019. Disorders of riboflavin metabolism.. J Inherit Metab Dis 42(4):608-619 PMID: 30680745
- 6. Qi B et al.. 2017. A vitamin-B2-sensing mechanism that regulates gut protease activity to impact animal's food behavior and growth.. Elife 6 PMID: 28569665
- 7. Yu L et al.. 2017. Dietary vitamin B2 intake and breast cancer risk: a systematic review and meta-analysis.. Arch Gynecol Obstet 295(3):721-729 PMID: 28035488
- 8. Nolan A et al.. 1991. Recurrent aphthous ulceration: vitamin B1, B2 and B6 status and response to replacement therapy.. J Oral Pathol Med 20(8):389-91 PMID: 1941656
